Skip to main content
Demo
Company record · Marche-en-Famenne
Belgian companySituation normaleSociété à responsabilité limitée

THERACELL ADVANCED BIOTECHNOLOGY (Belgium)

Enterprise number
0731.712.273
VAT number
BE0731712273
Registered office
Aye, Rue de la Science 8, 6900 Marche-en-Famenne
See the 13 companies at this address
Incorporated on
30 July 2019
Website
Official sources·CBE·NBB: Central Balance Sheet Office·Belgian Official Gazette·Map
Members only
Health score
Show the scoreLog in
Latest financial year
2022
m07-f model
Size
Not published
Workforce not declared
Equity
-€179.1K
Financial year 2022
Net result
-€128.3K
Financial year 2022

Profile

Official information from the CBE (FPS Economy).

THERACELL ADVANCED BIOTECHNOLOGY (Belgium) is a Belgian company (Société à responsabilité limitée) whose registered office is established at 6900 Marche-en-Famenne. Its main activity falls under “Recherche-développement en biotechnologie” (NACE 72101).

Legal form
Société à responsabilité limitée
Legal situation
Situation normale
Date of incorporation
30 July 2019
Main activity (NACE)
72101Recherche-développement en biotechnologie

An activity that is, on the face of it, not covered by anti-money-laundering law. Learn more

Secondary activities

3 additional NACE codes declared.

Your risk analysis on this company

AML Company ran THERACELL ADVANCED BIOTECHNOLOGY (Belgium) through your due diligence questionnaire. Here are the first findings.

  • What is the geographic exposure of the client and of its transactions?

    Belgium only· Registered office published in the register

  • What is the company's solvency and lifecycle status?

    Trading, no proceedings· Legal situation published in the register

The rest of the analysis

Sanctions screening, politically exposed persons, ultimate beneficial owners, source of funds: AML Company runs them, documents them and keeps the proof in your file.

Run the full analysis

Log in

This preview is not a due diligence measure: it pre-qualifies questions from public data. Identifying the client and its ultimate beneficial owners requires documents collected and verified.

Finances & financial health

Annual accounts filed with the Central Balance Sheet Office (CBSO, National Bank of Belgium) and an aggregate health score (Altman Z″ model, completed with qualitative factors).

Zone Altman
Grade
Computed on
Financial trend

Equity & result

EquityResult
Key figures by financial year
Financial yearEquityResult
2022-€179,076-€128,310
2020––

Financial ratios

Solvency, liquidity and profitability, computed year by year from the filed annual accounts.

Solvency
-54,6%
Financial year 2022

Equity / balance sheet total

Liquidity
19,28 x
Financial year 2022

Current assets / debts due within one year

Net margin
-

This year's filing does not carry the item the calculation needs.

Result for the year / turnover

Operating margin
-

This year's filing does not carry the item the calculation needs.

Operating result / turnover

Long-term debt
149,4%
Financial year 2022

Debts due after one year / balance sheet total

Return on equity
-

The filed denominator is zero or negative: the ratio would carry no meaning.

Result for the year / equity

Year-on-year comparison
Ratio20222020Trend
Solvency
-54,6%
-
-
Liquidity
19,28 x
-
-
Net margin--
-
Operating margin--
-
Long-term debt
149,4%
-
-
Return on equity--
-

Ratios computed by AML Company from the items filed in the balance sheet and the income statement. They are not filed figures as such: the underlying amounts appear in the key figures above.

Filing history (2)▾
Financial yearFilingFiling typeModelSource
01/01/2022 → 31/12/202214/07/2023Initialm07-fBNB
29/07/2019 → 31/12/202030/09/2021Initialm07-fBNB

Source: CBSO (NBB) filings, Belgian chart-of-accounts headings 9904 (result), 10/15 (equity), 9900 (gross margin), 9087 (workforce in FTE). Data available for filings from 2022 onwards.

Health score and detailed factors

The grade, the score out of 100, the Altman Z″ zone and the list of public alerts are for members only.

Unlock

Notices in the Belgian Official Gazette

Official acts and notices: incorporation, changes to the articles, appointments, dissolutions.

Source: Belgian Official Gazette (FPS Justice). The links open the official PDFs.

Frequently asked questions about THERACELL ADVANCED BIOTECHNOLOGY (Belgium)

Quick answers on THERACELL ADVANCED BIOTECHNOLOGY (Belgium)'s identity, contact details and official CBE information.

What is THERACELL ADVANCED BIOTECHNOLOGY (Belgium)'s enterprise number (CBE)?
THERACELL ADVANCED BIOTECHNOLOGY (Belgium)'s official enterprise number with the Crossroads Bank for Enterprises (CBE) is 0731712273. This unique number identifies the company with every Belgian administration.
What is THERACELL ADVANCED BIOTECHNOLOGY (Belgium)'s VAT number?
THERACELL ADVANCED BIOTECHNOLOGY (Belgium)'s intra-Community VAT number is BE0731712273. It is the CBE number prefixed with “BE” and enables trade within the European Union.
Where is THERACELL ADVANCED BIOTECHNOLOGY (Belgium)'s registered office?
THERACELL ADVANCED BIOTECHNOLOGY (Belgium)'s registered office is located at Aye, Rue de la Science 8, 6900 Marche-en-Famenne, Belgium. This address is the official one declared with the CBE.
What is THERACELL ADVANCED BIOTECHNOLOGY (Belgium)'s legal form?
THERACELL ADVANCED BIOTECHNOLOGY (Belgium) is incorporated under the legal form “Société à responsabilité limitée”. This form determines its legal and tax regime and its publication duties towards the Belgian Official Gazette.
When was THERACELL ADVANCED BIOTECHNOLOGY (Belgium) incorporated?
THERACELL ADVANCED BIOTECHNOLOGY (Belgium) was entered in the Crossroads Bank for Enterprises on 30 July 2019. This date is the official start of activity declared with the CBE.
Is THERACELL ADVANCED BIOTECHNOLOGY (Belgium) still active?
Yes, THERACELL ADVANCED BIOTECHNOLOGY (Belgium) is currently listed as an active company with the Crossroads Bank for Enterprises (CBE).
What is THERACELL ADVANCED BIOTECHNOLOGY (Belgium)'s main activity?
THERACELL ADVANCED BIOTECHNOLOGY (Belgium)'s declared main activity is: Recherche-développement en biotechnologie (NACE code 72101). This NACE code officially classifies the company in the European nomenclature of economic activities.
How can THERACELL ADVANCED BIOTECHNOLOGY (Belgium) be contacted?
You can contact THERACELL ADVANCED BIOTECHNOLOGY (Belgium) through its website https://theracell.eu. These details come from the public information declared with the CBE.
Has THERACELL ADVANCED BIOTECHNOLOGY (Belgium) filed its annual accounts?
Yes. THERACELL ADVANCED BIOTECHNOLOGY (Belgium)'s latest annual accounts were filed with the Central Balance Sheet Office (CBSO, National Bank of Belgium) on 14 July 2023, for the financial year ended 31 December 2022. The filings can be consulted publicly with the NBB.
Which official notices concern THERACELL ADVANCED BIOTECHNOLOGY (Belgium)?
2 official notices about THERACELL ADVANCED BIOTECHNOLOGY (Belgium) are available in the Belgian Official Gazette: incorporation, changes to the articles, appointments, dissolutions. Every one of these acts is listed on this page with a link to the official PDF.
Is THERACELL ADVANCED BIOTECHNOLOGY (Belgium) subject to anti-money-laundering obligations in Belgium?
On the face of it, no. THERACELL ADVANCED BIOTECHNOLOGY (Belgium)'s declared activity is not among the professions expressly covered by the Act of 18 September 2017. This general information is not legal advice.

Company timeline

Every dated event in the company's life, from filed accounts to notices published in the Belgian Official Gazette, in a single thread.

Timeline
4 events
Filter the timeline by event type

10 AI-analysed dimensions are not shown.

  1. 2023
    1. 14 July 2023Annual accounts filed·Financial year ended 31 December 2022 · Model m07-fFiled accounts2023-00235065
    2. 18 April 2023Registered officeView the notice23052562
  2. 2021
    1. 30 September 2021Annual accounts filed·Financial year ended 31 December 2020 · Model m07-fFiled accounts2021-69100525
  3. 2019
    1. 1 August 2019IncorporationView the notice19328847

Registry record since 7 September 2026

The KBO publishes its changes as a monthly delta and never restates the past: our record starts on that date, not at the company's incorporation. No change recorded since that date. A missing row says nothing about the company, only about how far back our record goes.

AI insights · Pro AI plan

AI extraction of strategic AML data

The official notices in the Belgian Official Gazette are analysed by our AI engine to extract automatically the information that matters for your due diligence and your AML duties.

  • Legal life
  • Restructuring
  • Capital
  • Legal form
  • Incorporation
  • Directors
  • Beneficial owners
  • Registered office
  • Company name
  • Notarial deeds
Unlock AI insightsSee the plans

Similar companies

Same business sector and geographic area.

CER-Groupe

0420.654.158
6900 Marche-en-Famenne

Orgenesis (Belgium)

0540.866.555
6900 Marche-en-Famenne

DOCTEUR FADY MOKADDEM

0473.147.885
6800 Libramont-Chevigny

DR. DEVLEESCHOUWER DIRK

0477.045.307
9660 Brakel

CABINET MEDICAL DOCTEUR PH. FONTAINE

0438.316.571
5020 Namur

DOCTEUR PIERRE HENRI ARNOULD

0460.417.527
6800 Libramont-Chevigny

RECHERCHE ET SANTE

0417.663.192
1410 Waterloo

BEX

0432.848.048
3512 Hasselt

Consultants for Research in Imaging and Spectroscopy - Innovative Solutions

0449.686.654
7503 Tournai
AML Company

Step it up
Full analysis unlocked.

Create an account to unlock the detailed analysis: health score, full history, alerts and PDF exports.

Create an account

    We respect your privacy

    We use cookies that are essential to running the site and, with your consent, anonymised audience-measurement cookies (hosted in the EU) to improve our services. Learn more.